# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-21-265927
Filing Date
2021-09-07
Accepted
2021-09-07 06:07:20
Documents
45
Period of Report
2021-09-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d211517d8k.htm iXBRL | 8-K | 24368
2 | EX-99.1 | d211517dex991.htm | EX-99.1 | 51430
6 | GRAPHIC | g211517ex99_1p10g1.jpg | GRAPHIC | 285977
7 | GRAPHIC | g211517ex99_1p11g1.jpg | GRAPHIC | 372274
8 | GRAPHIC | g211517ex99_1p12g1.jpg | GRAPHIC | 437597
9 | GRAPHIC | g211517ex99_1p13g1.jpg | GRAPHIC | 361446
10 | GRAPHIC | g211517ex99_1p14g1.jpg | GRAPHIC | 185493
11 | GRAPHIC | g211517ex99_1p15g1.jpg | GRAPHIC | 441205
12 | GRAPHIC | g211517ex99_1p16g1.jpg | GRAPHIC | 276933
13 | GRAPHIC | g211517ex99_1p17g1.jpg | GRAPHIC | 358442
14 | GRAPHIC | g211517ex99_1p18g1.jpg | GRAPHIC | 358797
15 | GRAPHIC | g211517ex99_1p19g1.jpg | GRAPHIC | 438783
16 | GRAPHIC | g211517ex99_1p1g1.jpg | GRAPHIC | 196573
17 | GRAPHIC | g211517ex99_1p20g1.jpg | GRAPHIC | 465623
18 | GRAPHIC | g211517ex99_1p21g1.jpg | GRAPHIC | 297650
19 | GRAPHIC | g211517ex99_1p22g1.jpg | GRAPHIC | 452337
20 | GRAPHIC | g211517ex99_1p23g1.jpg | GRAPHIC | 349506
21 | GRAPHIC | g211517ex99_1p24g1.jpg | GRAPHIC | 483713
22 | GRAPHIC | g211517ex99_1p25g1.jpg | GRAPHIC | 405969
23 | GRAPHIC | g211517ex99_1p26g1.jpg | GRAPHIC | 402395
24 | GRAPHIC | g211517ex99_1p27g1.jpg | GRAPHIC | 432950
25 | GRAPHIC | g211517ex99_1p28g1.jpg | GRAPHIC | 354460
26 | GRAPHIC | g211517ex99_1p29g1.jpg | GRAPHIC | 438342
27 | GRAPHIC | g211517ex99_1p2g1.jpg | GRAPHIC | 711366
28 | GRAPHIC | g211517ex99_1p30g1.jpg | GRAPHIC | 402612
29 | GRAPHIC | g211517ex99_1p31g1.jpg | GRAPHIC | 279903
30 | GRAPHIC | g211517ex99_1p32g1.jpg | GRAPHIC | 155568
31 | GRAPHIC | g211517ex99_1p3g1.jpg | GRAPHIC | 334739
32 | GRAPHIC | g211517ex99_1p4g1.jpg | GRAPHIC | 500097
33 | GRAPHIC | g211517ex99_1p5g1.jpg | GRAPHIC | 462428
34 | GRAPHIC | g211517ex99_1p6g1.jpg | GRAPHIC | 286733
35 | GRAPHIC | g211517ex99_1p7g1.jpg | GRAPHIC | 342160
36 | GRAPHIC | g211517ex99_1p8g1.jpg | GRAPHIC | 544681
37 | GRAPHIC | g211517ex99_1p9g1.jpg | GRAPHIC | 357575
| Complete submission text file | 0001193125-21-265927.txt |  | 16982191

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | cbio-20210907.xsd | EX-101.SCH | 2924
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | cbio-20210907_lab.xml | EX-101.LAB | 18138
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | cbio-20210907_pre.xml | EX-101.PRE | 11429
38 | EXTRACTED XBRL INSTANCE DOCUMENT | d211517d8k_htm.xml | XML | 3341

Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 211238173
SIC: 2834 Pharmaceutical Preparations